Risk of Clinically Significant Graft-Versus-Host Disease (CSGVHD) in Children Receiving Allogeneic Hematopoietic Cell Transplant (HCT) for Non-Malignant Disorders in Florida (2010-2019)
2009 ◽
Vol 15
(3)
◽
pp. 370-376
◽
2019 ◽
Vol 67
◽
pp. 194-201
◽
2018 ◽
Vol 24
(3)
◽
pp. S335
2015 ◽
Vol 56
(8)
◽
pp. 2392-2397
◽
2020 ◽
Vol 26
(3)
◽
pp. S298-S299
2019 ◽
Vol 25
(3)
◽
pp. S242